Home
Sign In
About
Curriculum
Activity Information
Target Audience
Learning Objectives
Technical Requirements
The Curriculum in Iron Metabolism & Related Disorders is supported by an educational grant from
Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.
Course materials have been developed for use outside of the United States.
|
 |
|
|
|
|
|
|
Epidemiology and Disease Pathophysiology: Thalassaemia
In this course, Ali Taher, MD provides clinicians with a complete overview of the etiology and clinical features of β-thalassaemia, including β-thalassaemia major and β-thalassaemia intermedia. Additionally, he discusses the development of iron overload and the current treatment options, including iron chelation therapy, in order to provide clinicians with state-of the-science options to improve their patients' outcomes.
|
|
Faculty
|
|
|
Ali T. Taher, MD
Professor
Department of Internal Medicine
American University of Beirut Medical Center
Beirut, Lebanon
|
|
|
Target Audience
This activity is designed for haematologists, medical oncologists, haematology-oncology specialists, and other healthcare professionals involved in the screening, evaluation, treatment, and management of adults and children with iron overload, resulting from the spectrum of chronic iron overload diseases.
|
Learning Objectives
After participating in this activity, participants should be better able to:
- Distinguish ß-thalassaemia major (TM) and ß-thalassaemia intermedia (TI) with respect to molecular basis and clinical presentation and features in order to improve diagnosis and management.
- Explain the development, consequences, and treatment of iron overload in patients with ß-thalassaemia in order to improve patient outcomes.
|
Disclosure Information
Ali T. Taher, MD, is on the speakers bureau of and on the advisory board for Novartis Pharmaceuticals Corporation. Prof. Taher has disclosed that he will not reference any unlabeled/unapproved uses of drugs or devices.
|
|
|
|
|
|
|
